申请人:Hoffmann-La Roche Inc.
公开号:US06218385B1
公开(公告)日:2001-04-17
The present invention is concerned with 1,2,4,5-tetrahydro-benzo[d]azepin derivatives as well as with their pharmaceutically acceptable salts in their racemic and optically active form, which compounds are antagonists at metabotropic glutamate receptors and therefore useful for the treatment of diseases related to these receptors.
本发明涉及1,2,4,5-四氢苯并[d]氮杂环己烷衍生物,以及它们的药用盐,无论是它们的外消旋形式还是光学活性形式,这些化合物是代谢型谷氨酸受体拮抗剂,因此对于治疗与这些受体相关的疾病是有用的。